IBDEI1X1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30596,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30596,1,2,0)
 ;;=2^Ferumoxytol,Non-ESRD,1 MG
 ;;^UTILITY(U,$J,358.3,30596,1,3,0)
 ;;=3^Q0138
 ;;^UTILITY(U,$J,358.3,30597,0)
 ;;=Q0139^^122^1573^8^^^^1
 ;;^UTILITY(U,$J,358.3,30597,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30597,1,2,0)
 ;;=2^Ferumoxytol,ESRD Use,1 MG
 ;;^UTILITY(U,$J,358.3,30597,1,3,0)
 ;;=3^Q0139
 ;;^UTILITY(U,$J,358.3,30598,0)
 ;;=J1580^^122^1573^10^^^^1
 ;;^UTILITY(U,$J,358.3,30598,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30598,1,2,0)
 ;;=2^Garamycin Gentamicin up to 80 MG
 ;;^UTILITY(U,$J,358.3,30598,1,3,0)
 ;;=3^J1580
 ;;^UTILITY(U,$J,358.3,30599,0)
 ;;=J1644^^122^1573^12^^^^1
 ;;^UTILITY(U,$J,358.3,30599,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30599,1,2,0)
 ;;=2^Heparin Sodium per 1000 Units
 ;;^UTILITY(U,$J,358.3,30599,1,3,0)
 ;;=3^J1644
 ;;^UTILITY(U,$J,358.3,30600,0)
 ;;=96374^^122^1573^13^^^^1
 ;;^UTILITY(U,$J,358.3,30600,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30600,1,2,0)
 ;;=2^IV Push,Ther/Proph/Diag
 ;;^UTILITY(U,$J,358.3,30600,1,3,0)
 ;;=3^96374
 ;;^UTILITY(U,$J,358.3,30601,0)
 ;;=J1750^^122^1573^14^^^^1
 ;;^UTILITY(U,$J,358.3,30601,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30601,1,2,0)
 ;;=2^Iron Dextran 50 MG
 ;;^UTILITY(U,$J,358.3,30601,1,3,0)
 ;;=3^J1750
 ;;^UTILITY(U,$J,358.3,30602,0)
 ;;=B4189^^122^1573^15^^^^1
 ;;^UTILITY(U,$J,358.3,30602,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30602,1,2,0)
 ;;=2^Parenteral NutrSol 10-15 g Protein
 ;;^UTILITY(U,$J,358.3,30602,1,3,0)
 ;;=3^B4189
 ;;^UTILITY(U,$J,358.3,30603,0)
 ;;=J3370^^122^1573^16^^^^1
 ;;^UTILITY(U,$J,358.3,30603,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30603,1,2,0)
 ;;=2^Vancomycin HCL 500 MG
 ;;^UTILITY(U,$J,358.3,30603,1,3,0)
 ;;=3^J3370
 ;;^UTILITY(U,$J,358.3,30604,0)
 ;;=J0882^^122^1573^3^^^^1
 ;;^UTILITY(U,$J,358.3,30604,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30604,1,2,0)
 ;;=2^Darbepoetin Alfa,ESRD Use,1 MCG
 ;;^UTILITY(U,$J,358.3,30604,1,3,0)
 ;;=3^J0882
 ;;^UTILITY(U,$J,358.3,30605,0)
 ;;=J0881^^122^1573^4^^^^1
 ;;^UTILITY(U,$J,358.3,30605,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30605,1,2,0)
 ;;=2^Darbepoetin Alfa,Non-ESRD,1 MCG
 ;;^UTILITY(U,$J,358.3,30605,1,3,0)
 ;;=3^J0881
 ;;^UTILITY(U,$J,358.3,30606,0)
 ;;=J0885^^122^1573^7^^^^1
 ;;^UTILITY(U,$J,358.3,30606,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30606,1,2,0)
 ;;=2^Epoetin Alfa,Non-ESRD,1000 Units
 ;;^UTILITY(U,$J,358.3,30606,1,3,0)
 ;;=3^J0885
 ;;^UTILITY(U,$J,358.3,30607,0)
 ;;=J1642^^122^1573^11^^^^1
 ;;^UTILITY(U,$J,358.3,30607,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30607,1,2,0)
 ;;=2^Heparin Sodium per 10 Units
 ;;^UTILITY(U,$J,358.3,30607,1,3,0)
 ;;=3^J1642
 ;;^UTILITY(U,$J,358.3,30608,0)
 ;;=Q4081^^122^1573^6^^^^1
 ;;^UTILITY(U,$J,358.3,30608,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30608,1,2,0)
 ;;=2^Epoetin Alfa,ESRD Use,100 Units
 ;;^UTILITY(U,$J,358.3,30608,1,3,0)
 ;;=3^Q4081
 ;;^UTILITY(U,$J,358.3,30609,0)
 ;;=92950^^122^1574^5^^^^1
 ;;^UTILITY(U,$J,358.3,30609,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30609,1,2,0)
 ;;=2^Heart/Lung Resuscitation CPR
 ;;^UTILITY(U,$J,358.3,30609,1,3,0)
 ;;=3^92950
 ;;^UTILITY(U,$J,358.3,30610,0)
 ;;=93224^^122^1574^3^^^^1
 ;;^UTILITY(U,$J,358.3,30610,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30610,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Intrp & Rpt
 ;;^UTILITY(U,$J,358.3,30610,1,3,0)
 ;;=3^93224
